Eden Research (LON:EDEN) Announces Earnings Results

Eden Research (LON:EDEN) released its quarterly earnings results on Wednesday. The company reported GBX (0.36) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.

Eden Research Stock Performance

Shares of LON EDEN traded down GBX 0.17 during trading hours on Wednesday, hitting GBX 2.18. 1,070,606 shares of the company’s stock were exchanged, compared to its average volume of 587,206. The company’s 50-day moving average price is GBX 2.73 and its 200-day moving average price is GBX 3.17. Eden Research has a 1-year low of GBX 1.96 and a 1-year high of GBX 5. The stock has a market capitalization of £17.51 million, a price-to-earnings ratio of -4.92 and a beta of 1.57. The company has a debt-to-equity ratio of 1.43, a current ratio of 2.25 and a quick ratio of 2.42.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.